Navigation Links
LifeCycle Pharma Forms Scientific Advisory Board in Solid Organ Transplantation

LifeCycle Pharma has established a Scientific Advisory Board for its transplantation programs. In addition, LifeCycle Pharma announces the expansion of its United States (U.S.) clinical development department with the addition of Drs. Rob Gordon and Larry Chodoff LifeCycle Pharma A/S OMX:LCP) today announced the formation of an international Scientific Advisory Board (SAB) of experts in the field of organ transplantation. The SAB will provide counsel to the company's management team as LifeCycle Pharma expands its development programs within the area of solid organ transplantation.

The SAB consists of six internationally recognized thought leaders from the U.S. and Europe, including:

Dr. Rita R. Alloway, Director of Transplant Clinical Research, University of Cincinnati
Dr. Klemens Budde, Medical Director of Transplantation, Charite University Hospital, Berlin
Dr. Robert S. Gaston, Medical Director of Kidney & Pancreas Transplantation, University of Alabama, Birmingham
Dr. Josep M. Grinyo, Chief, Division of Nephrology, University Hospital of Bellvitge, Barcelona
Dr. John R. Lake, Director, Gastroenterology Division, University of Minnesota, Minneapolis
Dr. Marc D. Pescovitz, Professor of Surgery and Microbiology/Immunology, Indiana University Medical Center, Indianapolis

'As LifeCycle Pharma advances its product portfolio within organ transplantation, the Scientific Advisory Board will provide an instrumental role in guiding our research and development programs,' said Dr. Flemming Ornskov, President and CEO of LifeCycle. 'We have attracted established, and highly respected members of the transplantation field who will play a pivotal role in LifeCycle Pharma bringing innovation to this disease area,' added Dr.Orsnkov.

In addition, LifeCycle Pharma has strengthened its clinical development capabilities in the U.S. with the addition of Drs. Robe rt Gordon, as Senior Director of Medical and Clinical Research, and Larry Chodoff, as Director of Medical Affairs Transplantation.

Dr. Gordon is an internationally respected transplant surgeon who has spent more then 30 years in academia and industry. He was a member of the team that was headed by the world renowned transplant surgeon, Dr. Thomas Starzl, at the University of Colorado and the University of Pittsburgh. From 1992 until he moved to industry, Dr. Gordon was Professor of Surgery and Director of the Liver Transplant Service at Emory University Hospital in Atlanta, Georgia. Most recently, Dr. Gordon was the Senior Medical Director for Transplantation at Roche Laboratories in Nutley, New Jersey.

After 17 years of practice at the Mount Sinai Medical Center in New York, New York, Dr. Larry Chodoff joined Novartis Pharmaceuticals Corporation in 1997, as Associate Director of Clinical Research, managing global research and development programs in organ transplantation and autoimmune diseases.

Prior to joining LifeCycle Pharma, Dr. Chodoff held the position of Medical Liaison in Transplantation and Immunology at Roche Laboratories. Dr. Chodoff received his Pharm.D. from the University of the Pacific School of Pharmacy in 1979.

'Their combined experience of more than 50 years of working within the area of organ transplantation will be a great asset for LifeCycle Pharma as our LCP-Tacro program enters Phase II clinical trials,' said Dr. Michael Beckert, Chief Medical Officer at LifeCycle Pharma, who will oversee the responsibilities of Drs. Rob Gordon and Larry Chodoff.




'"/>




Related medicine news :

1. LifeCycle Pharma to Initiate Phase II Clinical Trial of LCP-Tacro for Organ Transplantation
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
4. Pharma cos must forge Strategic alliances
5. Medicis Pharmaceutical company enters pediatric market
6. Pharma majors gear to supply anti-anthrax drug
7. Pharmacies in for a dose of bitter medicine
8. Andhra Pradesh to set up Pharma City
9. Sun Pharma to launch chiral version of omeprazole soon
10. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
11. Pharmacia may take 51.5 percent Abbott stake
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... ... , ... Mediaplanet is proud to announce the launch of ... treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and physicians manage ... in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. “This ...
(Date:12/2/2016)... ... , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology ... health technology on the market can deliver all that rejiva can. , “Rejiva promotes ... their health than the usual heart rate and steps taken”, adds Evens Augustin, CEO ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today ... intelligent, connected applications, was named the best Sales Team of 2016 as part ... was made today by the Software & Information Industry Association (SIIA), the principal ...
(Date:11/30/2016)... ... , ... "I hate when the mixture of saliva and toothpaste runs down ... from Bridgewater, N.J. "I thought that there had to be a way to prevent ... patent-pending DEFLECTOR to prevent saliva and toothpaste from running down the brush handle onto ...
(Date:11/30/2016)... U.K. (PRWEB) , ... November 30, 2016 , ... ... address the tech functions and stylish design wanted by today’s consumers at an ... Cronovo Co-Founder Darin Philip says the new watch is “a game changer” when ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... WOONSOCKET, R.I. , Dec. 2, 2016 ... hold its annual Analyst Day in New York City on Thursday, December ... the CVS Health leadership team will provide an in-depth ... and enhance shareholder value. The company will also discuss ... audio and video webcast of the event will be ...
(Date:12/2/2016)... 2, 2016 Orthopedic Implants (Including Spinal ... Expected to Gain a Significant Market Share Owing to a ... ... According to a new report by ... Sterile Packaging: Clamshell Product Type Segment Projected to Witness a ...
(Date:12/2/2016)... N.J. , Dec. 2, 2016   CytoSorbents ... immunotherapy leader commercializing its European Union approved CytoSorb ... and cardiac surgery patients worldwide, announced that Dr. ... the 9th Annual LD Micro Main Event ... , 2016 at the Luxe Sunset Boulevard Hotel in ...
Breaking Medicine Technology: